Trilogy Capital’s Vanguard FTSE Europe ETF VGK Stock Holding History

Trilogy Capital’s Portfolio VGK Stock Details VGK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-409	Closed	-$23K	–	548
2018 Q3	$23K	Buy	409 +101	+33%	+$5.72K	﹤0.01%	264
2018 Q2	$17K	Buy	308 +105	+52%	+$6.18K	﹤0.01%	267
2018 Q1	$12K	Buy	+203	New	+$12.2K	﹤0.01%	253

Other funds holding VGK

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

USAA

United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Trilogy Capital's VGK Position: Q4 2018 in Review

Trilogy Capital sold out of Vanguard FTSE Europe ETF (VGK) in Q4 2018, closing a stake of 409 shares — an estimated $23K sold.

Trilogy Capital first reported a position in VGK in Q1 2018 and held it in 3 quarters. The position peaked at $23K in Q3 2018. 520 funds tracked by Wall St. Rank hold VGK as of Q4 2018.

Trilogy Capital reported no remaining Vanguard FTSE Europe ETF position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 409 Vanguard FTSE Europe ETF shares in Q4 2018, an estimated $23K.
Trilogy Capital first reported a position in Vanguard FTSE Europe ETF in Q1 2018 and held it in 3 quarters.
Trilogy Capital's Vanguard FTSE Europe ETF position peaked at $23K in Q3 2018.
520 funds tracked by Wall St. Rank held Vanguard FTSE Europe ETF as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.